Utility of Serum 1,3-ß-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis.

Egger, Matthias; Prüller, Florian; Krause, Robert; Prattes, Juergen; Hoenigl, Martin

Egger, Matthias; Prüller, Florian; Krause, Robert; Prattes, Juergen; Hoenigl, Martin.

Egger M; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Grazgrid.11598.34, Graz, Austria.
Prüller F; BioTechMed-Graz, Graz, Austria.
Krause R; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Grazgrid.11598.34, Graz, Austria.
Prattes J; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Grazgrid.11598.34, Graz, Austria.
Hoenigl M; BioTechMed-Graz, Graz, Austria.

Microbiol Spectr ; 10(3): e0137322, 2022 06 29.

Article in English | MEDLINE | ID: covidwho-1986340

Subject(s)

Aspergillosis; COVID-19; Pulmonary Aspergillosis; COVID-19/diagnosis; Glucans; Humans; Mannans; Pulmonary Aspergillosis/diagnosis

Keywords

3-beta-d-glucan; Covid-19; Covid-19-associated pulmonary aspergillosis; ICU; diagnostics; ß-d-glucan

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspergillosis / Pulmonary Aspergillosis / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Microbiol Spectr Year: 2022 Document Type: Article Affiliation country: Spectrum.01373-22

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google